Clinical Trial Detail

NCT ID NCT02950064
Title A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Placon Therapeutics
Indications

ovarian cancer

prostate cancer

Advanced Solid Tumor

pancreatic cancer

triple-receptor negative breast cancer

Therapies

BTP-114

Age Groups: adult senior

Additional content available in CKB BOOST